Recently Dr. Michael Fulks commented on 2020 mortality data from JAMA, citing an increase of 17.7% from 2019 to 2020… Read More
Tags: Cancer, Insurance, Life Insurance, Mortality, Retirement
Dr. Michael Fulks, Consulting Medical Director to CRL, comments on the 2020 leading causes of death in a COVID-19 world…. Read More
Tags: Cancer, Covid 19, Heart Disease, Life Insurance, Mortality
Urine protein tests offer a simple way for insurance companies to obtain an important predictor of life risk. CRL recently… Read More
Tags: Healthcare, Kidney, Life Insurance, Medical Research, Mortality
A fundamental underwriting principal is to treat like risks in a similar manner. This fairness doctrine is a key to… Read More
Tags: Cigarettes, Insurance, Mortality, Nicotine, Risk
See below for details on the latest CRL acquisition. We are pleased to share that CRL has acquired Confirm BioSciences, a… Read More
Tags: Acquisition, Business, Laboratory, Life Insurance, Mortality
There are many articles that can help answer the question of applicant hemoglobin A1c values, including this study from CRL: Relationship… Read More
Tags: Diabetes, Diabetic, Life Insurance, Mortality, Underwriting
Dr. Heather Fehling, Chief Scientific Officer of Molecular Diagnostics at CRL, was honored to join the Society of Actuaries Epigenetics… Read More
Tags: Epigenetics, Genetics, Life Insurance, Mortality, Science
Dr. Michael Fulks, MD, comments on earlier research regarding the relative mortality in apparently healthy adults with various urine protein/creatinine… Read More
Tags: Lab Tests, Life Insurance, Mortality, Underwriting, Urinalysis
Are you giving systolic blood pressure (SBP) the credit or debit it deserves? Review your company’s preferred criteria and note… Read More
Tags: Blood Pressure, Bp, Hypertension, Life Insurance, Mortality
How do you find a very expensive early mortality risk, most of which is the result of undiagnosed — but… Read More
Tags: Cancer, Lab Tests, Life Insurance, Mortality, Underwriting